IL17A and colitis: Conversely, Lowe et al. reported that mice with colitis-associated colorectal cancer deficient in TLR2 easily developed significantly more and larger colorectal tumors compared with wild-type mice, together with increased expressions of IL-6, IL-17A, and phospho-STAT3 (Lowe et al., 2010).